Direct-to-consumer marketing: how has it fared? von Fintor, Lou

Volltext

Eastern European drug makers are newest players in volatile market von Fintor, L

Volltext

Looking abroad: do funding imbalances affect foreign competition? von Fintor, L

Volltext

Biomedical research 'revolution' drives push for balanced funding von Fintor, L

Volltext

New Montreal gene centers boost basic, clinical cancer research von Fintor, L

Volltext

Canadians push national cancer strategy von Fintor, L

Volltext

The Canadian Health Care System von Fintor, L.

Volltext

Breast cancer group targets 'shareholder activism' at Avon von Fintor, Lou

Volltext

Guidelines outline categories of patients eligible for marijuana von Fintor, L

Volltext

Canada's marijuana regulations raise efficacy, safety issues von Fintor, L

Volltext

Canada-U.S. mortality comparison highlights analytical pitfalls von Fintor, L

Volltext

International data comparisons: caveat emptor von Fintor, L

Volltext

Increase in drug tampering reports sparks new security considerations von Fintor, Lou

Volltext

Counterfeit Cases Set Stage for Today's Laws, Safety Mechanisms von Fintor, L.

Volltext

Vagaries of research publishing again under the microscope von Fintor, Lou

Volltext

New uniform population standard better reflects U.S. cancer burden von Fintor, Lou

Volltext

Health agencies adopt new disease classification codes von Fintor, Lou

Volltext

AstraZeneca reprimanded for nolvadex advertisement von Fintor, Lou

Volltext

Melanoma vaccine momentum spurs interest, investment von Fintor, L

Volltext

Cancer cryosurgery potentially 'hot' for patients, new markets von Fintor, L

Volltext